NovaBridge Biosciences (NBP) Long-Term Investments (2020 - 2026)

NovaBridge Biosciences (NBP) has reported Long-Term Investments for 6 consecutive years, with $37.2 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Long-Term Investments rose 20.82% year-over-year to $37.2 million; the TTM figure through Dec 2025 stood at $37.2 million (up 20.82% YoY), while the FY2025 annual figure was $37.2 million, up 20.82% from the prior year.
• Long-Term Investments declined to $37.2 million in Q4 2025 per NBP's latest filing, from $40.3 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $55.1 billion in Q4 2021 and bottomed at $1.6 million in Q2 2023.
• Historically, Long-Term Investments has averaged $5.0 billion across 5 years, with a median of $32.5 million in 2022.
• Annual changes were most pronounced in 2021 — Long-Term Investments surged 424764.78% — and 2022, when it slumped 99.99%.
• NovaBridge Biosciences' Long-Term Investments stood at $55.1 billion in 2021, then plunged by 99.99% to $4.3 million in 2022, then plunged by 61.31% to $1.7 million in 2023, then jumped by 1736.91% to $30.8 million in 2024, then climbed by 20.82% to $37.2 million in 2025.
• Business Quant data shows NBP's Long-Term Investments at $37.2 million in Q4 2025, $40.3 million in Q3 2025, and $34.5 million in Q2 2025.